James Hardie Industries plc reports profit fall: Is it a bargain?

Building materials supplier James Hardie Industries plc (ASX:JHX) has reported an 8% drop in profits for the first nine months to 31 December 2014.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Building materials supplier, James Hardie Industries plc (ASX: JHX) today announced an 8% drop in net profit for the nine months ended 31 December, 2014.

James Hardie, a leading supplier of building products which derives around 80% of revenues overseas, reported $US1.25 billion of net sales from operating activities.

However, a lower adjustment for asbestos, reflecting the non-cash foreign exchange translation (from USD to AUD), resulted in earnings before interest and tax, or EBIT, climbing just 1% over the prior period. Combined with a higher tax bill, earnings per share dropped to US 59 cents, from US 65 cents a year earlier.

CEO Louis Gries said: "While our operating environment in the US has improved marginally compared to the prior corresponding quarter, we are yet to see the previous anticipated accelerated growth in the US residential market."

"When we look at the US housing market, and the broader US economy as a whole, we see continued uncertainty in the short term," Mr Gries said. "However, our more positive view on the medium and longer-term outlook remains unchanged."

Should you buy James Hardie shares?

Whilst the first half may have proven to be a tough ride for investors, management anticipate net operating profit excluding asbestos to be between US$210 million and US$222 million, assuming housing conditions in the United States continue to improve and exchange rates remain largely unchanged. For comparison adjusted net operating profit for 2014 was $US197.2 million, thus a profit increase of around 9% can be expected.

Armed with a generous dividend yield and growing earnings per share, James Hardie may – in hindsight – appear cheap if it can hit its targets in the US. However, personally, I'd rather wait for a pullback in share price before hitting the buy button.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »